中泰化學(002092.SZ):擬2.63億元收購控股股東旗下三公司若干股權
格隆匯5月13日丨中泰化學(002092.SZ)公佈,公司根據戰略發展需要,為了聚焦主業、優化管理層級,增強公司可持續發展能力和核心競爭力,對與控股股東新疆中泰(集團)有限責任公司(簡稱“中泰集團”)交叉持股公司進行了梳理,公司擬收購中泰集團持有的金暉兆豐7.992%的股份(對價約為9651.91萬元)、華泰重化工1.6736%的股權(對價約為1.64億元)、中泰鹽化3.41%的股權(對價為245.71萬元)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.